Similar articles

• Comparative clinical trial of ceftazidime and imipenem/cilastatin in patients with severe nosocomial pneumonias and septicaemias.

  Hartenauer U, Weilemann LS, Bodmann KF, Ritzerfeld WW, Asmus S, Koch EM. Hartenauer U, et al. J Hosp Infect. 1990 Apr;15 Suppl A:61-4. doi: 10.1016/0195-6701(90)90081-x. J Hosp Infect. 1990. PMID: 1971647 Clinical Trial.
• Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.

  Norrby SR, Finch RG, Glauser M. Norrby SR, et al. J Antimicrob Chemother. 1993 Jun;31(6):927-37. doi: 10.1093/jac/31.6.927. J Antimicrob Chemother. 1993. PMID: 8360130 Clinical Trial.
• Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.

  Vazquez JA, González Patzán LD, Stricklin D, Duttaroy DD, Kreidly Z, Lipka J, Sable C. Vazquez JA, et al. Curr Med Res Opin. 2012 Dec;28(12):1921-31. doi: 10.1185/03007995.2012.748653. Epub 2012 Nov 21. Curr Med Res Opin. 2012. PMID: 23145859 Clinical Trial.
• Changing role of carbapenems in the treatment of lower respiratory tract infections.

  Lode H, Hamacher J, Eller J, Schaberg T. Lode H, et al. Scand J Infect Dis Suppl. 1995;96:17-23. Scand J Infect Dis Suppl. 1995. PMID: 7652498 Review.
• [Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].

  Tallarigo C, Comunale L, Baldassarre R, Poletti G. Tallarigo C, et al. Minerva Urol Nefrol. 1995 Sep;47(3):147-56. Minerva Urol Nefrol. 1995. PMID: 8815553 Review. Italian.